<DOC>
	<DOC>NCT02344082</DOC>
	<brief_summary>This prospective study will include both an intervention and control arm. The control arm will receive face-to-face pharmacy clinic visits per standard of care. The intervention arm will receive pharmacy clinic visits plus additional telephone follow-up. Patients with a hemoglobin A1c in the last 3 months greater than 9% will be eligible. Eligible patients must have a primary care physician at Johns Hopkins Outpatient Center (JHOC) or East Baltimore Medical Center (EBMC). Purpose: To compare the change in hemoglobin A1c over the 3 month study period in the intervention group in which patients participate in telemedicine, to a control group in which they do not</brief_summary>
	<brief_title>Pharmacists Provide Telemedicine in Addition to Clinic Visits to Improve Diabetes Management</brief_title>
	<detailed_description />
	<criteria>Adult patients with a primary care provider at JHOC or EMBC Patients have seen primary care provider within last 6 months Patients with hemoglobin A1c greater than 9% Patients &lt;18 years of age Patients with previously established care with JHH ambulatory care pharmacist Patients with communication barriers who do not have a caregiver Patients with new diagnosis of diabetes Patients who are pregnant or planning to become pregnant during the time of the study Patients followed by Endocrinology or Diabetes Center</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>